|
||

* Section of Microbiology, University of California, Davis, California 95616; The yeast vacuolar protein aminopeptidase I
(API) is synthesized as a cytosolic precursor that is
transported to the vacuole by a nonclassical targeting
mechanism. Recent genetic studies indicate that the
biosynthetic pathway that transports API uses many of
the same molecular components as the degradative
autophagy pathway. This overlap coupled with both in
vitro and in vivo analysis of API import suggested that,
like autophagy, API transport is vesicular. Subcellular
fractionation experiments demonstrate that API precursor (prAPI) initially enters a nonvacuolar cytosolic compartment. In addition, subvacuolar vesicles containing prAPI were purified from a mutant strain defective in breakdown of autophagosomes, further indicating that prAPI enters the vacuole inside a vesicle. The
purified subvacuolar vesicles do not appear to contain
vacuolar marker proteins. Immunogold EM confirms
that prAPI is localized in cytosolic and in subvacuolar
vesicles in a mutant strain defective in autophagic body
degradation. These data suggest that cytosolic vesicles
containing prAPI fuse with the vacuole to release a
membrane-bounded intermediate compartment that is
subsequently broken down, allowing API maturation.
Department of Chemical and Biological Sciences,
Faculty of Science, Japan Women's University, Tokyo 112, Japan; and § Department of Cell Biology, National Institute for Basic
Biology, Okazaki 444, Japan
This article has been cited by other articles:
|
|